Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Insilico Medicine revenue
Insilico Medicine's revenue is $4.0 million.
What is Insilico Medicine's revenue?
- Insilico Medicine has 30 employees, and the revenue per employee ratio is $133,333.
- Insilico Medicine peak revenue was $4.0M in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Insilico Medicine financing
Insilico Medicine received early financing of $300.0K on 2014-04-16.
| Series | Round size | Date |
|---|---|---|
| Seed | $300K | 04/2014 |
| Convertible Note | $1.2M | 11/2014 |
| Series A | $2.8M | 02/2017 |
| Series A | $4M | 07/2017 |
| Series A | $6M | 06/2018 |
| Series B | $37M | 09/2019 |
| Series C | $255M | 06/2021 |
Insilico Medicine investors
| Investors | Security type |
|---|---|
| Deep Knowledge Ventures | Seed |
| Deep Knowledge Ventures | Convertible Note |
| A-Level Capital | Series A |
| Jim Mellon | Series A |
| Juvenescence | Series A |
| Pavilion Capital | Series A |
| WuXi AppTec Co Ltd | Series A |
| Bold Capital Partners | Series A |
| Eight Roads Ventures | Series B |
| Lilly Asia Ventures | Series B |
| Baidu Ventures | Series B |
| F-Prime Capital | Series B |
| Pavilion Capital | Series B |
| Longevity Vision Fund | Series B |
| Qiming Venture Partners | Series B |
| Bold Capital Partners | Series B |
| Sinovation Ventures | Series B |
| CPE | Series C |
| Eight Roads Ventures | Series C |
| Lilly Asia Ventures | Series C |
| Sage Partners | Series C |
| Baidu Ventures | Series C |
| Pavilion Capital | Series C |
| Sinovation Ventures | Series C |
| B Capital Group | Series C |
| Warburg Pincus | Series C |
| Mirae Asset Capital | Series C |
| Sequoia Capital China | Series C |
| President International Development Corp | Series C |
| Lake Bleu Capital | Series C |
| Maison Capital | Series C |
| OrbiMed Advisors | Series C |
| Qiming Venture Partners | Series C |
| Deerfield | Series C |
| Bold Capital Partners | Series C |
| Formic Ventures | Series C |
Insilico Medicine competitors
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| NantHealth | $87,637 | $67.0M | 543 | 11 |
| Arcturus Therapeutics | $91,074 | $152.3M | 150 | 6 |
| Twist Bioscience | $98,778 | $313.0M | 414 | 75 |
| Editas Medicine | $86,368 | $32.3M | 133 | - |
| Intarcia Therapeutics | $76,606 | $70.0M | 44 | - |
| Vertex Pharmaceuticals | $95,952 | $11.0B | 3,400 | 297 |
| ProofPilot | $56,034 | $1.6M | 5 | 4 |
| Complete Genomics | $88,842 | $19.3M | 200 | - |
| Practice Fusion | $116,110 | $38.9M | 161 | - |
| SillaJen | $68,581 | - | 100 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Insilico Medicine, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Insilico Medicine. The employee data is based on information from people who have self-reported their past or current employments at Insilico Medicine. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Insilico Medicine. The data presented on this page does not represent the view of Insilico Medicine and its employees or that of Zippia.
Insilico Medicine may also be known as or be related to Insilico Medicine, Insilico Medicine, Inc and Insilico Medicine, Inc.